These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7134500)

  • 1. Development of pancreatic glucagon-specific radioimmunoassay with use of synthetic human glucagon (19-29) as immunogen.
    Mihara S; Yanaihara C; Nishiura M; Ogawa H; Yanaihara N
    Radioisotopes; 1982 May; 31(5):240-4. PubMed ID: 7134500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunoassay of plasma pancreatic glucagon using a specific anti-glucagon sera (OAL-123) (author's transl)].
    Nishimura N; Chikamori K; Saito S
    Horumon To Rinsho; 1980 Sep; 28(9):1109-13. PubMed ID: 7460363
    [No Abstract]   [Full Text] [Related]  

  • 3. Production of antisera to des Asn28 Thr29 Homoser27-glucagon; the development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma.
    Nishino T; Kodaira T; Shin S; Imagawa K; Yanaihara N; Shima K; Kumahara Y
    Endocrinol Jpn; 1981 Aug; 28(4):419-27. PubMed ID: 6897834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and evaluation of glucagon antibodies for radioimmunoassay.
    Holst JJ; Aasted B
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):715-26. PubMed ID: 4479706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radioligand assay: method and application. II. Effect of glucagon coupling on the production of glucagon antisera with suitable binding parameters for radioimmunoassay].
    Ziegler M; Keilacker H; Woltanski KP; Besch W; Schubert J
    Acta Biol Med Ger; 1980; 39(2-3):305-14. PubMed ID: 6775484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for pancreatic glucagon based on specific derivatisation of the hormone.
    Nooijen WJ; Koppert PW
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():118-22. PubMed ID: 6167195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma pancreatic glucagon in chronic liver disease, with special reference to comparison of 2 pancreatic glucagon-specific antisera and effects of bile acids].
    Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
    Nihon Shokakibyo Gakkai Zasshi; 1983 Aug; 80(8):1610-6. PubMed ID: 6632335
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon radioimmunoassay: technical problems and recent data.
    Assan R; Tchobroutsky G; Derot M
    Horm Metab Res; 1971; 3():Suppl 3:82-90. PubMed ID: 5170500
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.
    Imagawa K; Nishino T; Shin S; Uehata S; Hashimura E; Yanaihara C; Yanaihara N
    Endocrinol Jpn; 1979 Feb; 26(1):123-31. PubMed ID: 86440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a specific antiserum by synthetic C-terminal fragment of glucagon.
    Ohneda A; Watanabe K; Wakimatsu M; Fujino M
    Horm Metab Res; 1979 Aug; 11(8):463-8. PubMed ID: 574120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.
    Vranic M; Pek S; Kawamori R
    Diabetes; 1974 Nov; 23(11):905-12. PubMed ID: 4430418
    [No Abstract]   [Full Text] [Related]  

  • 13. A solid phase radioimmunoassay for pancreatic glucagon.
    Lundqvist G; Edwards J; Wide L
    Ups J Med Sci; 1976; 81(2):65-9. PubMed ID: 785743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
    Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1208-13. PubMed ID: 6471533
    [No Abstract]   [Full Text] [Related]  

  • 15. [Radioimmunologic study of natural and synthetic glucagon and similar synthetic peptides].
    Assan R; Drouet J; Rosselin G; Wünsch E; Schröder E
    Pathol Biol (Paris); 1969; 17(15):757-62. PubMed ID: 4907910
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological and immunological activity of pancreatic glucagon and enteric glucagon-like immunoreactivity.
    Faloona GR; Unger RH
    Isr J Med Sci; 1974 Oct; 10(10):1324-31. PubMed ID: 4611965
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagon radioimmunoassay by using anti-pancreatic glucagon 19-29 sera: evaluation of a new commercial kit (Dainabot) (author's transl)].
    Katsuta T; Ishihara M; Harada Y; Yamawaki M; Ueyama K
    Kaku Igaku; 1981 May; 18(4):533-40. PubMed ID: 7289215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specific radioimmunoassay of pancreatic glucagon. Results in new-born and in child (author's transl)].
    Ruitton A; Frederich F
    Diabete Metab; 1975 Sep; 1(3):143-50. PubMed ID: 1234577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA).
    Boden G; Chey WY
    Endocrinology; 1973 Jun; 92(6):1617-24. PubMed ID: 4350502
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proceedings: Radioimmunoassay of glucagon: evaluation of antibody production].
    Ito M; Sasaki H
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):245. PubMed ID: 4476371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.